sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Fetal Bovine Serum Market Size, Share & Trends Analysis - Global opportunity analysis and industry forecast 2030

Fetal Bovine Serum Market Size, Share & Trends Analysis -...

Home / Categories / Healthcare
Fetal Bovine Serum Market Size, Share & Trends Analysis - Global opportunity analysis and industry forecast 2030
Fetal Bovine Serum Market Size,...
Report Code
RO14/128/1608

Publish Date
05/Dec/2021

Pages
190
PRICE
$ 4570/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5450/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7695/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

The global fetal bovine serum market revenue was US$ 840 million in 2021. The global fetal bovine serum market revenue is forecast to reach US$ 1,375.53 million by 2030, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2022-2030.

A fetus' blood contains a liquid rich in nutrients called fetal bovine serum. Cell culture media commonly consist of fetal bovine serum (FBS), which derives from the fetuses of cows. It contains several nutritional and macromolecular factors necessary for cell growth. It also contains amino acids, sugars, lipids, hormones, and low levels of gamma globulin. Its uses are in various applications, including supplying essential nutrients and promoting cellular survival and growth in eukaryotic cell culture. Research, manufacturing, biotech drugs, and controlling vaccines for both humans and animals use this technology. 

Factors Influencing Market Growth

  • A rise in R&D activities towards developing novel biopharmaceuticals and the growing pharmaceutical industry are forecast to drive the global fetal bovine serum market growth.
  • Developed and developing countries invest and fund more in research interventions, which encourages the global fetal bovine serum market growth. 
  • A lack of skilled personnel and ethical concerns about misuse of biotechnology research practices may have a negative impact on the global fetal bovine serum market growth.
  • The untapped potential of emerging markets will likely turn out to be lucrative for the key players operating in the overall fetal bovine serum market in the near future.

Impact Analysis of COVID-19

A sudden increase in COVID-19 has significantly affected the growth of the global fetal bovine serum industry. The pandemic has increased the demand for fetal bovine serum, especially in biotechnological and biopharmaceutical facilities working on developing an effective vaccine against COVID-19. Growing demand for fetal bovine serum has driven the market's growth during the pandemic.

Regional Insights

In terms of geographic share, North America dominated the fetal bovine serum market in 2020 and is forecast to maintain its dominance during the forecast period. There has been a significant increase in R&D activities to develop antibody-based therapy for various diseases, and there is a well-established healthcare infrastructure in the region. In addition, market players in this region are increasing their investment in research and development activities related to drugs that require fetal bovine serum. These factors contribute to the growth of the fetal bovine serum market in the region.

Leading Competitors

The leading prominent companies profiled in the global fetal bovine serum market are:

  • Danaher (Cytiva)
  • Merck KGaA (Sigma Aldrich)
  • HiMedia Laboratories Pvt. Limited
  • Bio-Techne Corporation
  • Sera Scandia (Biowest)
  • Sartorius (Biological Industries)
  • Atlas Biologicals
  • Rocky Mountain Biologicals
  • PAN-Biotech
  • Thermo Fisher Scientific Incorporated
  • Other Prominent Players

Scope of the Report

The global fetal bovine serum market segmentation focuses on Application, End-User, and Region.

Segmentation based on Application

  • Biopharmaceuticals
  • Human and Animal Vaccine
  • Others (IVF and IVD)

Segmentation based on End-User

  • Biotechnology & Pharmaceutical Industries
  • Academic Institutes
  • Others (Research labs, Diagnostic labs, CRO, CMO, and IVF centers)

Segmentation based on Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Brazil
  • Argentina
  • Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com